Marry Eibrink

Marry Eibrink is a Researcher in the Department of Pediatrics at Erasmus University Rotterdam, specializing in pediatric oncology and long-term effects of cancer treatments. Her work focuses on childhood cancer survivors, particularly addressing late effects such as cardiovascular complications, metabolic disorders, and psychosocial outcomes. She is a key member of the DCCSS-LATER consortium and Dutch LATER Study group, leading collaborative projects on survivorship care and guideline harmonization.

Her research interests include understanding the long-term health consequences of pediatric cancer therapies, improving surveillance strategies, and enhancing quality of life for survivors. She has contributed to international guidelines on metabolic syndrome surveillance in cancer survivors and employs advanced statistical methods like structural equation modeling to explore causal factors in chronic conditions.

Collaborations span multiple institutions, emphasizing interdisciplinary approaches to pediatric oncology and survivorship research. Her work has been recognized through citations and media mentions, reflecting its impact on clinical practice and patient care.